E0767 HCPCS Level II code: Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories
E0767 is the HCPCS code for “Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
E0767Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories
Short description: Intrabuc am rf emf cancer tx
HCPCS · United States
Medicare details
The indicators CMS publishes with E0767 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- DMEPOS fee schedule – Carrier priced (e.g., not otherwise classified, individual determination, carrier discretion, gap-filled amounts)
- Type of service
- Other medical items or services
- BETOS category
- Other DME
- Added
- Oct 1, 2024
Where E0767 sits
- 1E codesDurable medical equipment
- 2Active code E0767Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code E0767 mean?
E0767 is the HCPCS code for “Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover E0767?
CMS lists E0767’s Medicare coverage as “Carrier judgment” and its pricing as “DMEPOS fee schedule – Carrier priced (e.g., not otherwise classified, individual determination, carrier discretion, gap-filled amounts)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside E0767
All E codesE0760Osteogenesis stimulator, low intensity ultrasound, non-invasiveE0761Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment deviceE0762Transcutaneous electrical joint stimulation device system, includes all accessoriesE0764Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire…E0765Fda approved nerve stimulator, for treatment of nausea and vomitingE0766Electrical stimulation device used for cancer treatment, includes all accessories, any typeE0769Electrical stimulation or electromagnetic wound treatment device, not otherwise classifiedE0770Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specifiedE0776Iv poleE0779Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greaterE0780Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hoursE0781Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient